• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PROGENIKA BIOPHARMA S.A. ID CORE XT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PROGENIKA BIOPHARMA S.A. ID CORE XT Back to Search Results
Model Number 1291720000
Device Problem False Positive Result (1227)
Patient Problem Patient Problem/Medical Problem (2688)
Event Date 05/22/2020
Event Type  malfunction  
Manufacturer Narrative
The genomic dna sample was sent to grifols ih center for sequencing.Next generation sequencing interrogated jk gene proximal promoter and exons 1-10 and the genotype jk*a(28a, 226a, 303a), jk*b was identified.Isbt describes variant jk*a: c.(28g>a) as jk*01w.03 associated to jka+w.Isbt describes variant jk*a: c.(226g>a) as jk*01w.04 associated to jka+w.Isbt describes variants jk*a: c.28g>a, jk*a: c.226g>a , jk*a: c.303g>a and jk*a: c.588a>g as allele jk*01n.20 associated to jka-.This last association although not complete is in concordance with serology result jka-.Id core xt reported a predicted jka+ phenotype, but serology test reported jka- result, due to the presence of variants jk*a: c.28g>a, jk*a: c.226g>a and jk*a: c.303g>a previously described as likely associated to jka-.This false positive result obtained by id core xt is considered a discrepant result and then a malfunction.This limitation is covered by the general assay limitations described in the id core xt package insert (limitations 1 and 10).
 
Event Description
The customer reported a possible discrepancy.The serological phenotype was jka negative and the id core xt genotype suggested a phenotype of jka positive.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ID CORE XT
Type of Device
ID CORE XT
Manufacturer (Section D)
PROGENIKA BIOPHARMA S.A.
ibaizabal bidea, edificio 504
parque tecnológico de bizkaia
derio, bizkaia 48160
SP  48160
Manufacturer (Section G)
PROGENIKA BIOPHARMA S.A.
ibaizabal bidea, edificio 504
parque tecnológico de bizkaia
derio, bizkaia 48160
SP   48160
Manufacturer Contact
diego tejedor
ibaizabal bidea, edificio 504
parque tecnológico de bizkaia
derio, bizkaia 48160
SP   48160
MDR Report Key10230738
MDR Text Key219199627
Report Number3006413195-2020-00008
Device Sequence Number1
Product Code PEP
UDI-Device Identifier08437013457019
UDI-Public(01)08437013457019(17)081020(10)0203000019
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
BP170154
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,user facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 07/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/03/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Expiration Date08/10/2020
Device Model Number1291720000
Device Catalogue Number1021720000
Device Lot Number0203000019
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/03/2020
Was Device Evaluated by Manufacturer? No
Date Device Manufactured05/14/2019
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Removal/Correction NumberN/A
Patient Sequence Number1
-
-